Ista Gains North American Rights To Bepotastine For Nasal Allergies From Tanabe Seiyaku
This article was originally published in The Pink Sheet Daily
Executive Summary
H1 receptor antagonist will enter clinic for nasal indication in late 2008/early 2009, firm tells “The Pink Sheet” DAILY.